Mellows has 25 years’ experience in commercial real estate and heads up Savills UK science group. He specialises in advising science-related occupiers needing R&D, lab and manufacturing space, as well as landlords and developers looking to deliver specialist science related space across the UK. Mellows has advised on the acquisition of more than 600,000 sq ft of space over the past three years for the likes of Autolus, Quell Therapeutics, DNAe, Achilles Therapeutics, Avacta, Freeline Therapeutics, OchreBio and Omass. Key development and leasing instructions include St John’s College Oxford, Stanhope & Cadillac Fairview’s 1m sq ft Oxford North development, ARC Group’s Manbre Wharf in Hammersmith, a 250,000 sq ft life sciences-focused scheme, Birmingham University, and Bruntwood SciTech’s 600,000 sq ft Birmingham Health and Innovation Campus. He also advised UBS/REEF on the prelet to Autolus at the Forge, Stevenage, for an 85,000 sq ft GMP facility, where there is scope for another 500,000 sq ft of manufacturing space. Mellows is at the forefront of emerging science sector trends, providing advice around lab premiums, differing levels of lab space and service provision, to help the growing number of investors, landlords and developers looking to access this unique market.